Quantcast
Home > Quotes > AZN

Astrazeneca PLC Common Stock (AZN) Quote & Summary Data

AZN 
$37.38
*  
0.11
0.29%
Get AZN Alerts
*Delayed - data as of Sep. 19, 2018 13:41 ET  -  Find a broker to begin trading AZN now
Exchange:NYSE
Industry: Health Care
Community Rating:
View:    AZN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

1 Year Target
42
Today's High / Low
$ 37.495 / $ 37.27
Share Volume
1,414,159
90 Day Avg. Daily Volume
3,856,247
Previous Close
$ 37.49
52 Week High / Low
$ 39.7627 / $ 31.99
Market Cap
94,704,434,373
P/E Ratio
17.72
Forward P/E (1y)
22.32
Earnings Per Share (EPS)
$ 2.11
Annualized Dividend
$ .88
Ex Dividend Date
8/9/2018
Dividend Payment Date
9/10/2018
Current Yield
2.34 %
Beta
0

Intraday Chart

Shares Traded

Share Volume:
1,414,159
90 Day Avg. Daily Volume:
3,856,247

P/E Ratio

P/E Ratio:
17.72
Forward P/E (1y):
22.32
Earnings Per Share (EPS):
$ 2.11

Trading Range

The current last sale of $37.38 is 16.85% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 37.495 $ 39.7627
 Low: $ 37.27 $ 31.99

ETFs with AZN as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
3.55% Franklin FTSE United Kingdom ETF (FLGB) -1.07 (-4.18%)
2.12% Franklin LibertyQ International Equity Hedged ETF (FLQH) +1.07 (4.44%)
1.84% NuShares Enhanced Yield US Aggregate Bond ETF (NUDM) -0.68 (-2.52%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

The information (including tabular data) set forth under the headings "Additional Information--Shareholder Information--History and development of the Company" on page 229, "Strategic Report--Financial Review-- Externalisation Revenue" on pages 71 and 72, "Strategic Report--Financial Review--Financial position -- 31 December 2017-- Business combinations" on page 75, "--Investments, divestments and capital expenditure" on pages 77 and 78, "Financial Statements--Notes to the Group Financial Statements--Note 25--Acquisitions of business operations" on pages 173 and 174 and "Corporate Governance--Corporate Governance Report--Relations with shareholders" on page 96, in each case of AstraZeneca's "Annual Report and Form 20-F Information 2017" included as exhibit 15.1 to this Form 20-F dated March 6, 2018 is incorporated by reference. B.  ... More ...  


Risk Grade

Where does AZN fit in the risk graph?


Risk Grade Scale

Consensus Recommendation

Analyst Info